Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells
作者： Lewis L. Lanier , Joseph H. Phillips , Arnon Nagler
DOI:
关键词:
摘要: A method is disclosed for removing residual tumor cells from a patient with neoplastic disorder by treating in vitro cell preparation lymphokine activated cytotoxic cells.
lens.org 参考文章(7)
Curt I. Civin, Human stem cells ,(1984)
E Lotzová, C A Savary, Generation of NK cell activity from human bone marrow. Journal of Immunology. ,vol. 139, pp. 279- 284 ,(1987)
Steven A. Rosenbert, Adoptive immunotherapy as a treatment modality in humans ,(1986)
R B Herberman, E Lotzová, C A Savary, Induction of NK cell activity against fresh human leukemia in culture with interleukin 2. Journal of Immunology. ,vol. 138, pp. 2718- 2727 ,(1987)
A Nagler, P L Greenberg, L L Lanier, J H Phillips, The effects of recombinant interleukin 2-activated natural killer cells on autologous peripheral blood hematopoietic progenitors. Journal of Experimental Medicine. ,vol. 168, pp. 47- 54 ,(1988) , 10.1084/JEM.168.1.47
Anthony A. Rayner, Elizabeth A. Grimm, Michael T. Lotze, Elizabeth W. Chu, Steven A. Rosenberg, Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer. Cancer. ,vol. 55, pp. 1327- 1333 ,(1985) , 10.1002/1097-0142(19850315)55:6<1327::AID-CNCR2820550628>3.0.CO;2-O
Terrance A. Taforo, Pete M. Fernandes, Pharmaceutical compositions of microbially produced interleukin-2 ,(1985)